These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 2073992)

  • 1. Dihydropyrimidine dehydrogenase but not thymidylate synthase expression is associated with resistance to 5-fluorouracil in colorectal cancer.
    Nita ME; Tominaga O; Nagawa H; Tsuruo T; Muto T
    Hepatogastroenterology; 1998; 45(24):2117-22. PubMed ID: 9951876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterizations of derivatives of HCT116 colorectal cancer cells that are resistant to the chemotherapeutic agent 5-fluorouracil.
    de Angelis PM; Fjell B; Kravik KL; Haug T; Tunheim SH; Reichelt W; Beigi M; Clausen OP; Galteland E; Stokke T
    Int J Oncol; 2004 May; 24(5):1279-88. PubMed ID: 15067352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of methotrexate on cells chronically infected with vaccinia virus.
    Koziorowska J; Chlopkiewicz B
    Acta Microbiol Pol A; 1973; 5(3):238-9. PubMed ID: 4769560
    [No Abstract]   [Full Text] [Related]  

  • 4. An in vitro short time-high dose drug exposure assay for predicting 5FU-resistance of colorectal cancer.
    Fan CW; Fan HA; Hsu SH; Chan CC; Chen SY; Hsu YH; Chan EC
    Cancer Lett; 2004 Oct; 214(2):181-8. PubMed ID: 15363544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer.
    Okumura K; Shiomi H; Mekata E; Kaizuka M; Endo Y; Kurumi Y; Tani T
    Oncol Rep; 2006 Apr; 15(4):875-82. PubMed ID: 16525674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase.
    Huber BE; Austin EA; Good SS; Knick VC; Tibbels S; Richards CA
    Cancer Res; 1993 Oct; 53(19):4619-26. PubMed ID: 8402637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro models of human colorectal cancer.
    Williams AC; Hague A; Manning AM; Van der Stappen JW; Paraskeva C
    Cancer Surv; 1993; 16():15-29. PubMed ID: 8348534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cetuximab: new drug. Metastatic colorectal cancer: an inappropriate evaluation.
    Prescrire Int; 2005 Dec; 14(80):215-7. PubMed ID: 16400742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased EP4 receptor expression in colorectal cancer progression promotes cell growth and anchorage independence.
    Chell SD; Witherden IR; Dobson RR; Moorghen M; Herman AA; Qualtrough D; Williams AC; Paraskeva C
    Cancer Res; 2006 Mar; 66(6):3106-13. PubMed ID: 16540660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
    Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimetabolites.
    Chen AP; Grem JL
    Curr Opin Oncol; 1992 Dec; 4(6):1089-98. PubMed ID: 1457523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can antioxidants enhance chemotherapy?
    Gordon D
    Gastroenterology; 1998 Feb; 114(2):235. PubMed ID: 9453477
    [No Abstract]   [Full Text] [Related]  

  • 13. Carcinogenesis, prevention and treatment of colorectal cancer--State of the Art 2012. Introduction.
    Friess H; Bader FG; Schmid RM; von Delius S
    Dig Dis; 2012; 30 Suppl 2():1. PubMed ID: 23207925
    [No Abstract]   [Full Text] [Related]  

  • 14. Physiological and pharmacological determinants of sensitivity and resistance to 5-fluorouracil in lower animals and man.
    Ardalan B; Cooney D; Macdonald JS
    Adv Pharmacol Chemother; 1980; 17():289-321. PubMed ID: 7004142
    [No Abstract]   [Full Text] [Related]  

  • 15. [Colorectal carcinogenesis, tumor progression and chemoresistance].
    Veyrac M
    Gastroenterol Clin Biol; 1990; 14(12 ( Pt 2)):20D-24D. PubMed ID: 2073992
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sequential therapy with methotrexate and 5-fluorouracil in patients with advanced colorectal cancer pretreated with 5-fluorouracil plus folinic acid].
    Paoletti G; Di Lauro L; Gionfra T; Venturo I; Belli F; Squilloni E; Mariotti S; Fioretti G; Gemini M; Tersigni R; Lopez M
    Clin Ter; 1998; 149(2):105-8. PubMed ID: 9780473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. dUTP nucleotidohydrolase isoform expression in normal and neoplastic tissues: association with survival and response to 5-fluorouracil in colorectal cancer.
    Ladner RD; Lynch FJ; Groshen S; Xiong YP; Sherrod A; Caradonna SJ; Stoehlmacher J; Lenz HJ
    Cancer Res; 2000 Jul; 60(13):3493-503. PubMed ID: 10910061
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.